Formulation And Evaluation Of Terminalia Arjuna-Based Oral Suspension For Anti-Inflammatory Activity

Authors

  • Ayush Verma
  • Girish Kumar Vyas
  • Nitin Nama

Keywords:

Terminalia arjuna, oral suspension, anti-inflammatory, formulation stability, in vitro drug release

Abstract

The study focuses on the development and evaluation of an oral suspension containing Terminalia arjuna extract, a plant renowned for its anti-inflammatory, cardioprotective, and antioxidant properties. The formulation aimed to provide a stable, effective, and easily administered dosage form for potential cardiovascular health support. The extract was prepared from the bark of T. arjuna using ethanol, and the suspension was formulated with excipients like xanthan gum, sucrose, and preservatives. The final product was evaluated for physicochemical properties, stability, microbial safety, and in vitro drug release. Results indicated that the optimal formulation (F2) showed excellent stability, uniform drug content, and sustained release, with 80.5% drug release after 120 minutes. The formulation met all evaluation criteria, demonstrating its potential as a safe and effective therapeutic option for inflammation and cardiovascular conditions.

Downloads

Download data is not yet available.

References

Gupta, R., & Sharma, S. (2014). Terminalia arjuna: A comprehensive review on medicinal properties and its applications in health and disease. Journal of Pharmaceutical Sciences and Research, 6(12), 439-446.

Chopra, R. N., & Nayar, S. L. (1956). Glossary of Indian Medicinal Plants. CSIR Publication, New Delhi.

Bhat, S. A., & Qazi, P. H. (2019). Anti-inflammatory and antioxidant activities of Terminalia arjuna: A review. Asian Journal of Pharmaceutical and Clinical Research, 12(3), 1-7.

Rathi, A., & Singh, D. (2017). Phytochemical screening and therapeutic potential of Terminalia arjuna. Journal of Ayurveda and Integrative Medicine, 8(3), 160-169.

Patel K, Patel M. Formulation and evaluation of oral suspension of herbal extracts. Int J Pharm Sci Res. 2013;4(7):2410-2416.

Mishra D, Tiwari M. Development and evaluation of herbal oral suspension: A review. Int J Pharm Pharm Sci. 2015;7(3):7-13.

Vishwakarma G, Sharma S. Development and formulation of herbal oral suspensions: Techniques and applications. J Pharm Res Health Care. 2018;10(2):1-8.

Sharma A, Arora S. Evaluation of physicochemical properties of herbal drug formulations. J Appl Pharm Sci. 2017;7(6):112-118.

International Conference on Harmonisation (ICH). Stability testing of new drug substances and products Q1A(R2). ICH Harmonised Tripartite Guideline; 2003.

Bhalekar M, Chavan P. Stability studies of herbal pharmaceutical formulations. J Herb Med. 2016;10(4):98-103.

Shah M, Joshi S. Formulation and stability studies of oral herbal suspension containing aqueous extract of Terminalia arjuna. Int J Drug Dev Res. 2017;9(2):50-57.

Downloads

Published

2025-06-05

How to Cite

1.
Verma A, Kumar Vyas G, Nama N. Formulation And Evaluation Of Terminalia Arjuna-Based Oral Suspension For Anti-Inflammatory Activity. J Neonatal Surg [Internet]. 2025Jun.5 [cited 2025Jun.20];14(31S):59-64. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7083

Issue

Vol. 14 No. 31S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.